GA
FMI

Geneva Advisors’s Foundation Medicine, Inc. FMI Stock Holding History

Geneva Advisors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,640
Closed -$224K – 601
2013
Q3 		$224K Buy
+5,640
New +$208K ﹤0.01% 442

Other funds holding FMI

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PG
PEAK6 Group Chicago, Illinois $23.4B AUM 17.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geneva Advisors's FMI Position: Q4 2013 in Review

Geneva Advisors sold out of Foundation Medicine, Inc. (FMI) in Q4 2013, closing a stake of 5,640 shares — an estimated $224K sold.

Geneva Advisors first reported a position in FMI in Q3 2013 and held it in 1 quarter. The position peaked at $224K in Q3 2013. 85 funds tracked by Wall St. Rank hold FMI as of Q4 2013.

  • Geneva Advisors reported no remaining Foundation Medicine, Inc. position as of Q4 2013 after selling out during the quarter.
  • Geneva Advisors sold 5,640 Foundation Medicine, Inc. shares in Q4 2013, an estimated $224K.
  • Geneva Advisors first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 1 quarter.
  • Geneva Advisors's Foundation Medicine, Inc. position peaked at $224K in Q3 2013.
  • 85 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q4 2013.

Based on Geneva Advisors's 13F filing for Q4 2013, filed 4 Feb 2014.